160 related articles for article (PubMed ID: 8081994)
1. Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy.
Layward L; Allen AC; Harper SJ; Feehally J
Exp Nephrol; 1994; 2(1):24-9. PubMed ID: 8081994
[TBL] [Abstract][Full Text] [Related]
2. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
[TBL] [Abstract][Full Text] [Related]
3. Response to mucosal antigen challenge in IgA nephropathy.
Layward L; Allen AC; Hattersley JM; Harper SJ; Feehally J
Exp Nephrol; 1995; 3(5):300-7. PubMed ID: 7583052
[TBL] [Abstract][Full Text] [Related]
4. Immature B cells in fetal development and immunodeficiency: studies of IgM, IgG, IgA and IgD production in vitro using Epstein-Barr virus activation.
Pereira S; Webster D; Platts-Mills T
Eur J Immunol; 1982 Jul; 12(7):540-6. PubMed ID: 6288397
[TBL] [Abstract][Full Text] [Related]
5. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy.
van den Wall Bake AW; Daha MR; Radl J; Haaijman JJ; Van der Ark A; Valentijn RM; Van Es LA
Clin Exp Immunol; 1988 May; 72(2):321-5. PubMed ID: 3409549
[TBL] [Abstract][Full Text] [Related]
6. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.
van den Wall Bake AW; Daha MR; van der Ark A; Hiemstra PS; Radl J; van Es LA
Clin Exp Immunol; 1988 Oct; 74(1):115-20. PubMed ID: 3219797
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells of IgA nephropathy patients have an impaired capacity to induce IgA production in naïve B cells.
Eijgenraam JW; Woltman AM; Kamerling SW; Briere F; de Fijter JW; Daha MR; van Kooten C
Kidney Int; 2005 Oct; 68(4):1604-12. PubMed ID: 16164637
[TBL] [Abstract][Full Text] [Related]
8. Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy.
Goto T; Bandoh N; Yoshizaki T; Nozawa H; Takahara M; Ueda S; Hayashi T; Harabuchi Y
Clin Immunol; 2008 Mar; 126(3):260-9. PubMed ID: 18249037
[TBL] [Abstract][Full Text] [Related]
9. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
[TBL] [Abstract][Full Text] [Related]
10. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
Conley ME; Chan MA; Sigal NH
J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178
[TBL] [Abstract][Full Text] [Related]
11. Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions.
Zhang JJ; Jiang L; Liu G; Wang SX; Zou WZ; Zhang H; Zhao MH
Nephrology (Carlton); 2008 Dec; 13(8):712-20. PubMed ID: 18771467
[TBL] [Abstract][Full Text] [Related]
12. Induction of IgA against Haemophilus parainfluenzae antigens in tonsillar mononuclear cells from patients with IgA nephropathy.
Fujieda S; Suzuki S; Sunaga H; Yamamoto H; Seki M; Sugimoto H; Saito H
Clin Immunol; 2000 Jun; 95(3):235-43. PubMed ID: 10866131
[TBL] [Abstract][Full Text] [Related]
13. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
14. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Kobayashi Y; Hiki Y; Okamoto M
J Nephrol; 2005; 18(5):575-81. PubMed ID: 16299684
[TBL] [Abstract][Full Text] [Related]
15. Aberration of B and T cell subsets in patients with IgA nephropathy and membranous nephropathy.
Suga T; Endoh M; Tomino Y; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1984 Jun; 9(2):95-101. PubMed ID: 6398930
[TBL] [Abstract][Full Text] [Related]
16. Increased immunoglobulin-secreting cells in the blood of patients with active idiopathic IgA nephropathy.
Schena FP; Mastrolitti G; Fracasso AR; Pastore A; Ladisa N
Clin Nephrol; 1986 Oct; 26(4):163-8. PubMed ID: 3536230
[TBL] [Abstract][Full Text] [Related]
17. External suppression causes the low expression of the Cosmc gene in IgA nephropathy.
Qin W; Zhong X; Fan JM; Zhang YJ; Liu XR; Ma XY
Nephrol Dial Transplant; 2008 May; 23(5):1608-14. PubMed ID: 18202089
[TBL] [Abstract][Full Text] [Related]
18. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
Smith AC; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
[TBL] [Abstract][Full Text] [Related]
19. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
[TBL] [Abstract][Full Text] [Related]
20. In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy.
Allen AC; Layward L; Harper SJ; Feehally J
Exp Nephrol; 1994; 2(3):166-70. PubMed ID: 7922268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
